-
1
Treatment of psoriatic arthritis in a phase 3 randomised, placebo-controlled trial with apremilast, an oral phosphodiesterase 4 inhibitor
Veröffentlicht 2014kostenfrei
kostenfrei
kostenfrei
Elektronisch E-Book -
2
Long-term experience with apremilast in patients with psoriatic arthritis 5-year results from a PALACE 1–3 pooled analysis
Veröffentlicht 2019kostenfrei
kostenfrei
kostenfrei
Elektronisch E-Book